CLA

Status: Phase 2
Entry Type: Unknown
Molecule Category: UNKNOWN

Indications

Mesh Heading Maximum Phase Reference
Multiple Myeloma; Neoplasms, Plasma Cell Phase 2 ClinicalTrials
CONTENTS